Pharyngitis Treatment Market Growth and Trends: Key Insights into Market Opportunities for 2025-2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Pharyngitis Treatment Market?
The expected increase in strep throat transmission is predicted to foster the expansion of the pharyngitis treatment market. Strep throat, a communicable bacterial infection, has its primary effect on the throat and tonsils. Swift and efficient treatment of this condition with antibiotics can relieve symptoms, thwart complications, and decrease the risk of infection transmission. For example, in June 2022, as per the US-based government agency – the Centers for Disease Control and Prevention, roughly 14,000 to 25,000 cases of invasive group A strep disease are diagnosed in the United States every year. In addition, strep diseases result in 5.2 million outpatient visits and 2.8 million antibiotic prescriptions every year. The escalating transmission of strep throat, therefore, influences the pharyngitis treatment market. An uptick in influenza cases is anticipated to spur the growth of the pharyngitis treatment market in the future. Influenza, also known as the flu, is a communicable respiratory ailment initiated by influenza viruses. It is primarily treated by pharyngitis treatment which aids in relieving flu symptoms, like inflammation or irritation, and focuses on easing allergies and averting complications such as pneumonia and bronchitis. For instance, according to the European Centre for Disease Prevention and Control (ECDC), a government agency based in Sweden, during the 2022/2023 influenza season in the EU/EEA, the rate of positive influenza specimens touched 42% in the 51st week of 2022. The positivity rate then hovered around 28% from the 5th week to the 12th week of 2023. This increasing incidence, hence, is fueling the growth of the pharyngitis treatment market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12937&type=smp
#How Does the ProjectedPharyngitis Treatment Market Growth Compare Over the Forecast Period?
In recent times, the market size for pharyngitis treatment has experienced consistent growth. It is predicted to amplify from $2.27 billion in 2024 to $2.37 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%. The surge during the historic phase can be traced back to an increased occurrence and rising cases of the flu, an increased incidence of pharyngitis, enhanced awareness about pharyngitis, expanded access to healthcare facilities, and growing disposable incomes.
Anticipations are high for robust growth in the pharyngitis treatment market size in the forthcoming years. The market is expected to evolve to a size of $2.99 billion in 2029, with a compound annual growth rate (CAGR) of 6.0%. The anticipated growth during the projection period can be credited to the uptake of rapid point-of-care tests, the growing need for personalized medicine, the prevalence of antibiotic resistance, and the rising significance of hand hygiene. Key trends projected for this period consist of progress in research and development of pharyngitis treatments, integration of digital health technologies, and the rise of telehealth.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12937
What Are the Key Market Innovations in thePharyngitis Treatment Market Over the Coming Years?
Leading corporations in the pharyngitis treatment market are striving to develop ground-breaking products like oral monotherapy. This approach aims to boost patient compliance and offer effective and accessible treatment methods. Oral monotherapy means using a single oral medication to address a specific illness or disease. This treatment only uses one healing agent rather than mixed treatments to achieve the desired healing outcome. For example, in December 2023, the US FDA authorized the use of Fabhalta (iptacopan) by Novartis AG, a pharmaceutical entity based in Switzerland, marking it as the inaugural oral monotherapy for adults suffering from paroxysmal nocturnal hemoglobinuria (PNH). Obtained on [date], this progress symbolizes a substantial improvement by introducing a fresh treatment option that raises hemoglobin levels, thereby, eliminating the requirement for blood transfusions.
Who Are the Top Companies Driving Innovation and Growth in thePharyngitis Treatment Market?
Major companies operating in the pharyngitis treatment market are Pfizer Inc., GlaxoSmithKline PLC, Genentech Inc., Pliva Hrvatska D.o.o., Viatris Inc., Teva Pharmaceutical Industries Ltd., AbbVie Inc., Medtronic PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Pliva Hrvatska D.o.o., LivaNova PLC, Genentech Inc.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/pharyngitis-treatment-global-market-report
Which Key Market Segments Comprise the Pharyngitis Treatment Market and Drive Its Revenue Growth?
The pharyngitis treatment market covered in this report is segmented –
1) By Drug Class: Beta Lactams, Macrolides, Cephalosporins, Fluoroquinolones, Tetracycline, Other Drug Classes
2) By Source of Infection: Viral, Bacterial
3) By Modes Of Delivery: Oral, Intravenous, Intramuscular, Other Modes Of Delivery
4) By End-Users: Hospitals, Homecare, Specialty Centers, Other End-Users
Subsegments:
1) By Beta Lactams: Penicillins, Amoxicillin, Ampicillin
2) By Macrolides: Erythromycin, Azithromycin, Clarithromycin
3) By Cephalosporins: Cefuroxime, Ceftriaxone, Cefdinir
4) By Fluoroquinolones: Ciprofloxacin, Levofloxacin, Moxifloxacin
5) By Tetracycline: Doxycycline, Minocycline, Tetracycline
6) By Other Drug Classes: Clindamycin, Sulfonamides, Carbapenems
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12937&type=smp
Which Regions Are Emerging as Leaders in the Pharyngitis Treatment Market?
North America was the largest region in the pharyngitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharyngitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Reports Similar to the Global Pharyngitis Treatment Market 2025, By The Business Research Company:
Non-Steroidal Anti-inflammatory Drugs Global Market Report 2024
Leukemia Therapeutics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/leukemia-therapeutics-global-market-report
Digital Therapeutics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/digital-therapeutics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
